Search

Presents information on two conferences organized by the San Francisco Federal Reserve Bank's Research Department in 2004. Interest Rates and Monetary Policy conference; Emerging Markets and Macroeconomic Volatility: Lessons From a Decade of Financial Debacles conference.

The article presents a reprint of the "Economic Letter 2010-08" by the Federal Reserve Bank of San Francisco (FRBSF), which appeared in the March 15, 2010 issue. It summarizes the papers presented at the "Asia and the Global Financial Crisis" conference which was held last October 19-20, 2009 at the FRBSF in San Francisco, California. It discusses the national experiences of the financial crisis and the policy responses to the crisis.

The article presents a reprint of the 2008 Annual Pacific Basin Conference which appeared in the March 13, 2009 issue of the Federal Reserve Bank of San Francisco Economic Letter in California. The conference featured research papers on international topics, including trade and growth in Asia, global current account imbalances, and international investment patterns.

The article presents a reprint of the article "2007 Annual Pacific Basin Conference: Summary" presented at the Federal Reserve Bank of San Francisco held on June 8-9, 207. It discusses the implications of international pricing behavior and exchange rates, effectiveness of the implemented capital controls as well as foreign reserve management initiatives. It also highlights the degree of Asian financial market integrations as well as the enhancement of Chinese economic conditions.

We evaluated the formation of hemagglutination-inhibition (HI) antibodies in response to vaccination of 55 allogeneic and 23 autologous hematopoietic stem cell transplantation (HSCT) recipients with 3.75 μg inactivated influenza A/California/7/2009 (H1N1)v-like virus adjuvanted with AS03, given towards the end of the 2009 influenza pandemic. The 78 HSCT recipients, aged 11-72 (median 50) years, were vaccinated 1-290 (median 27) months post-HSCT. Of the 55 allogeneic HSCT recipients, 50.9% received reduced intensity conditioning, 74.5% had a sibling donor, 67.2% had active graft-versus-host disease and 43.6% were on steroid therapy. At baseline, 14/78 (17.9%) had HI titers ≥ 1:40. Blood samples of 77 patients were available post-1st vaccination; of these, 34 (44.2%) patients had HI titers ≥ 1:40. Blood samples of 43 patients were available post-2nd vaccination; of these, 21 (48.8%) had HI titers ≥ 1:40. There was a significant increase in HI titers ≥ 1:40 from baseline to both post-1st and 2nd vaccinations (p<0.001 each), and also from 1st to 2nd vaccination (p=0.008). In seronegative (HI titers <1:10) patients, whose sera were available before, after one dose, and after 2 doses of vaccine, seroconversion (to ≥ 1:40) occurred in 4/24 (16.7%) after 1-dose and in a total of 10/24 (41.7%) after 2-dose vaccination (p=0.031). Logistic regression analysis revealed that ≥ 1:40 HI titers were significantly associated with higher lymphocyte counts and higher HI baseline titers and, in allogeneic HSCT, with having a sibling donor and higher baseline titers. In conclusion, 2-dose vaccination with AS03-adjuvanted vaccine containing 3.75 μg antigen resulted in a statistically significant, yet limited, serological response. Therefore, additional precautions should be taken during influenza outbreaks., (Copyright © 2011 Elsevier Ltd. All rights reserved.)